These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 639835)

  • 1. Liver size and indices of drug metabolism in alcoholics.
    Pirttiaho HI; Sotaniemi EA; Ahlqvist J; Pitkänen U; Pelkonen RO
    Eur J Clin Pharmacol; 1978 Mar; 13(1):61-7. PubMed ID: 639835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum zinc and serum copper and indices of drug metabolism in alcoholics.
    Hartoma TR; Sotaniemi EA; Pelkonen O; Ahlqvist J
    Eur J Clin Pharmacol; 1977 Oct; 12(2):147-51. PubMed ID: 923628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological changes in the liver and indices of drug metabolism in alcoholics.
    Sotaniemi EA; Ahlqvist J; Pelkonen RO; Pirttiaho H; Luoma PV
    Eur J Clin Pharmacol; 1977 Apr; 11(4):295-303. PubMed ID: 862651
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver size and indices of drug metabolism in epileptics.
    Pirttiaho HI; Sotaniemi EA; Ahokas JT; Pitkänen U
    Br J Clin Pharmacol; 1978 Sep; 6(3):273-8. PubMed ID: 687506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug metabolism in man: in vivo and in vitro correlations.
    Sotaniemi EA; Pelkonen RO; Ahokas J; Ahlqvist J; Hokkanen OT
    Arch Toxicol Suppl; 1978; (1):339-42. PubMed ID: 277127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants.
    Pirttiaho HI; Sotaniemi EA; Pelkonen RO; Pitkänen U
    Eur J Clin Pharmacol; 1982; 22(5):441-5. PubMed ID: 7117357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug metabolism in diabetic subjects with fatty livers.
    Pirttiaho HI; Salmela PI; Sotaniemi EA; Pelkonen RO; Pitkänen U; Luoma PV
    Br J Clin Pharmacol; 1984 Dec; 18(6):895-9. PubMed ID: 6529530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver size in evaluating drug metabolizing capacity in man.
    Pirttiaho H
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):271-6. PubMed ID: 468452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrotic process and drug metabolism in alcoholic liver disease.
    Sotaniemi EA; Niemelä O; Risteli L; Stenbäck F; Pelkonen RO; Lahtela JT; Risteli J
    Clin Pharmacol Ther; 1986 Jul; 40(1):46-55. PubMed ID: 3720178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug metabolism in epileptics: in vivo and in vitro correlations.
    Sotaniemi EA; Pelkonen RO; Ahokas J; Pirttiaho HI; Ahlqvist J
    Br J Clin Pharmacol; 1978 Jan; 5(1):71-6. PubMed ID: 619937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug metabolism in alcoholics.
    Pelkonen O; Sotaniemi E
    Pharmacol Ther; 1982; 16(2):261-8. PubMed ID: 6752978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between lipid composition and drug metabolizing capacity of human liver.
    Savolainen MJ; Arranto AJ; Hassinen IE; Luoma PV; Pelkonen RO; Sotaniemi EA
    Eur J Clin Pharmacol; 1985; 27(6):727-32. PubMed ID: 3987778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of hepatic drug metabolism in alcoholics.
    Harman AW; Frewin DB; Priestly BG; Alexander CB
    Br J Clin Pharmacol; 1979 Jan; 7(1):45-8. PubMed ID: 760741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evaluation of the drug-metabolizing capacity in patients with diabetes mellitus.
    Salmela PI; Sotaniemi EA; Pelkonen RO
    Diabetes; 1980 Oct; 29(10):788-94. PubMed ID: 7439538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pericellular collagen in alcoholics with liver cirrhosis.
    Arranto AJ; Rautio A; Sotaniemi EA
    Res Commun Chem Pathol Pharmacol; 1982 Jan; 35(1):121-35. PubMed ID: 7058284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antipyrine clearance as a measure of drug metabolism in patients with diabetes mellitus].
    Oltmanns D; Dennin DE; Pentz R; Siegers CP
    Z Gastroenterol; 1984 Oct; 22(10):598-601. PubMed ID: 6506825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxidative hepatic metabolism in chronic alcoholics during the acute abstinence period: evaluation with antipyrine elimination].
    Soto Alvarez J; Alsar Ortiz MJ
    Rev Clin Esp; 1993 Jun; 193(2):60-3. PubMed ID: 8341815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of hepatic drug-metabolizing enxyme activity in man. Comparison of three different assays.
    Sotaniemi EA; Pelkonen RO; Puukka M
    Eur J Clin Pharmacol; 1980 Apr; 17(4):267-74. PubMed ID: 6105079
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of liver histology in chronic alcoholics with and without hepatitis C virus infection.
    Anderson S; Nevins CL; Green LK; El-Zimaity H; Anand BS
    Dig Dis Sci; 2001 Jul; 46(7):1393-8. PubMed ID: 11478489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic glutathione content in patients with alcoholic and non alcoholic liver diseases.
    Altomare E; Vendemiale G; Albano O
    Life Sci; 1988; 43(12):991-8. PubMed ID: 3172971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.